ClinicalTrials.gov
public full text
Public Domain
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
The purpose of this study is to determine the incidence of prostate cancer in men with the BRCa2 gene mutation as an independent indicator for prostate cancer screening.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations#806254
- Treatment and monitoring of men with metastatic castration-resistant prostate cancer#185247
- Risk-stratified cancer screening: A consensus-based conceptual framework from EUCanScreen#397807
- Self-reported last colorectal cancer screening test by sex, age and income quintile#790298
- MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies#1058099
Record · ID 857559
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive